U S PHYSICAL THERAPY INC /NV - COMMON (USPH)

CUSIP: 90337L108

Q2 2017 13F Holders as of 30 Jun 2017

Holder snapshot 7 signals
Share change
-102,414
Put/Call ratio
268%
SEC-reported price per share
$60.40
Indexed holders
170
Value change
-$6,817,725
Number of buys
68
Open additional details 1 more signal available
Number of sells
76
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
14,855,576

Security key

90337L108

Report period

Q2 2017

Indexed institutions

170

Top holders

10

Ownership snapshot

Top reported holders of USPH - U S PHYSICAL THERAPY INC /NV - COMMON (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock Finance, Inc.
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
31 Mar 2017
13F Highest disclosed value: $101,501,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BlackRock Finance, Inc. has the largest disclosed position value at $101.5M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value Top 5
BlackRock Finance, Inc. $101.5M
PRICE T ROWE ASSOCIATES INC /MD/ $76.15M
Neuberger Berman Group LLC $72.78M
VANGUARD GROUP INC $41.89M
ABERDEEN ASSET MANAGEMENT PLC/UK $40.6M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$101,501,000
1,554,353 shares
— 31 Mar 2017
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$76,152,000
1,166,184 shares
— 31 Mar 2017
Neuberger Berman Group LLC
13F
Company
13F
—
denominator unverified
$72,780,000
1,114,547 shares
— 31 Mar 2017
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$41,892,000
641,533 shares
— 31 Mar 2017
ABERDEEN ASSET MANAGEMENT PLC/UK
13F
Company
13F
—
denominator unverified
$40,601,000
621,754 shares
— 31 Mar 2017
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$39,506,000
605,000 shares
— 31 Mar 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
170
Shares
11,945,577
Indexed holders
170
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 indexed holders
175
Q2 2017 indexed holders
170
Indexed holder difference
-5
Investor Q1 2017 Shares Q2 2017 Shares Share Diff Share Chg % Q1 2017 value Q2 2017 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .